Shirley Dong

Shirley Dong is currently a Principal Associate Scientist in Process Development and Manufacturing Sciences at Kelonia Therapeutics, with a progressive career that includes roles as Senior Associate Scientist II and Associate Scientist II in the same field. Previously, Shirley served as an Associate Scientist in Upstream Process Development at Merck, where support was provided in optimizing monoclonal antibody production using CHO cells in various bioreactor systems. Early career experience includes modeling neurological diseases during an undergraduate research position at Penn State University, and contributing to phage isolation and genome annotation projects. Education consists of a Bachelor of Science in Biochemistry and Molecular Biology from Penn State University, completed in 2020.